Reply to Letter: "Adjuvant Antiviral Therapy With Nucleos(t)ide Analogs in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma''

被引：0
|
作者：
Lau, Wan Yee [1 ]
Yin, Lei
Huang, Gang
Zhou, Wei Ping
机构：
[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 3, Shanghai, Peoples R China
来源：
ANNALS OF SURGERY | 2017年 / 265卷 / 04期
关键词：
POSTOPERATIVE SURVIVAL; LIVER RESECTION; REACTIVATION; LAMIVUDINE;
D O I：
10.1097/SLA.0000000000001229
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E47 / E48
页数：3
相关论文
共 50 条
  • [31] High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Lin, Ching-Chung
    Bair, Ming-Jong
    Liu, Chia-Yuan
    Lin, Ze-Yu
    Chen, Chih-Jen
    Chen, Ming-Jen
    Chu, Cheng-Hsin
    Wang, Horng-Yuan
    Shih, Shou-Chuan
    Wang, Tsang-En
    MEDICINE, 2019, 98 (01) : E13818
  • [32] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, (03) : 158 - 164
  • [33] Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (39) : 6515 - 6522
  • [34] Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
    Il Han Song
    So Mi Kim
    Young Kwang Choo
    World Journal of Gastroenterology, 2013, (47) : 8867 - 8872
  • [35] Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
    Song, Il Han
    Kim, So Mi
    Choo, Young Kwang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (47) : 8867 - 8872
  • [36] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, 10 (03) : 158 - 164
  • [37] Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib
    Xu, Li
    Gao, Hengjun
    Huang, Junting
    Wang, Haoyuan
    Zhou, Zhongguo
    Zhang, Yaojun
    Li, Shaohua
    Chen, Minshan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (06) : 1032 - 1039
  • [38] Letter: nucleos(t)ide analogues are good, but not sufficient for hepatitis B virus clearance - Reply
    Liaw, Y. -F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) : 655 - 656
  • [39] RISK OF RECURRENCE IN HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA PATIENTS FAILED IN NUCLEOS(T) IDE ANALOGUES (NUCS) SECONDARY PREVENTION - A NATIONWIDE COHORT STUDY
    Lee, I-C.
    Wang, T-H.
    Hu, Y-W.
    Lin, H-C.
    Chao, Y.
    Huang, Y-H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S327 - S327
  • [40] Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Hiyama, Yuichi
    Fujino, Hatsue
    Namba, Maiko
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Oka, Shiro
    HEPATOLOGY RESEARCH, 2024, 54 (11) : 981 - 992
12345